ArticleJTO clinical and research reports2023
First-Line Lorlatinib Versus Crizotinib in
Hidetoshi Hayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleJTO clinical and research reports2023
Hidetoshi Hayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.